GAITHER JAMES C

Average Profitability
76.42%
Insider Buys Quantity
11
Insider Buys Sum
$21.44M
Insider Sells Quantity
17
Insider Sells Sum
$87.88M

Insider Activity of GAITHER JAMES C

The largest purchase of all time was on 2004-08-17 and amounted to 700532 shares of NVIDIA Corporation for $7.55M.

The largest sale of all time was on 2006-12-06 and amounted to 720000 shares of NVIDIA Corporation for $26.22M.

Biography of GAITHER JAMES C

No biography is available at this moment.

2020-03-31SaleNVIDIA Corporation
NVDA
director
15,669
0.0026%
$269.41$4.22M+93.38%
2019-09-10SaleNVIDIA Corporation
NVDA
director
10,000
0.0016%
$182.37$1.82M+43.64%
2018-05-31SaleNVIDIA Corporation
NVDA
director
45,000
0.0075%
$253.59$11.41M-25.12%
2018-02-15SaleNVIDIA Corporation
NVDA
director
40,359
0.0066%
$245.67$9.91M-1.8%
2017-06-21SaleNVIDIA Corporation
NVDA
director
27,269
0.0045%
$158.72$4.33M+33.25%
2016-11-17SaleNVIDIA Corporation
NVDA
director
35,000
0.0065%
$92.25$3.23M+49.56%
2016-03-01SaleNVIDIA Corporation
NVDA
director
80,000
0.0101%
$22.15$1.77M+90.75%
2014-11-24SaleNVIDIA Corporation
NVDA
director
96,000
0.0128%
$15.11$1.45M+7.47%
2014-10-01SaleMolecular Templates, Inc.
MTEM
10 percent owner
231,287
0.4191%
$3.77$872,415+14.2%
2014-06-20SaleMolecular Templates, Inc.
MTEM
10 percent owner
10,028
0.0166%
$4.01$40,193-3.93%
2013-05-31SaleMolecular Templates, Inc.
MTEM
10 percent owner
265,360
0.4656%
$5.72$1.52M-18.01%
2011-07-07SaleNVIDIA Corporation
NVDA
director
350,000
0.0579%
$15.65$5.48M-9.79%
2011-07-06SaleNVIDIA Corporation
NVDA
director
280,000
0.0446%
$15.01$4.2M-9.44%
2011-03-11PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
21,112
0.064%
$2.10$44,335-14.74%
2009-10-05PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
34,944
0.1703%
$1.91$66,743-12.5%
2009-02-06PurchaseCorcept Therapeutics Incorporated
CORT
10 percent owner
1.04M
1.4396%
$0.69$716,368+13%
2008-03-25PurchaseCorcept Therapeutics Incorporated
CORT
Former 10% Owner
710,692
1.7228%
$2.77$1.97M-45.07%
2007-09-04SaleNVIDIA Corporation
NVDA
director
90,000
0.0238%
$51.55$4.64M-33.79%
2007-08-17PurchaseCorcept Therapeutics Incorporated
CORT
Former 10% Owner
165,087
0.4266%
$2.10$346,683+24.77%
2007-03-30PurchaseCorcept Therapeutics Incorporated
CORT
Former 10% Owner
829,541
3.5543%
$1.00$829,541+197.78%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.